French Biotech Stock News

If you own Carrefour stock or you’re thinking about jumping in, you might be wondering what’s next for this retail heavyweight. Over the past month, Carrefour’s share price has climbed a sturdy 10.1%, putting a spring in the step of anyone watching for signs of growth. Even over the past week, the stock notched up another 3.3%. Despite these recent gains, the stock is still down 2.3% so far this year and trails by 4.0% over the last twelve months. Looking further back, there is a respectable...

MedinCell (ENXTPA:MEDCL) shares drew attention after the U.S. FDA cleared UZEDY, its long-acting risperidone injection, for use as a monthly treatment in adults with bipolar I disorder. This marks an added approval beyond schizophrenia. See our latest analysis for MedinCell. MedinCell’s share price has surged recently, booking a 64.2% gain over the past month and notching a remarkable 111.9% share price return in the last 90 days. Momentum clearly accelerated since the FDA expanded UZEDY’s...

Christian Dior SE recently reported that organic revenue grew 1% in the third quarter of 2025, while revenue for the first nine months was €58.09 billion, down from €60.75 billion in the same period last year. This turnaround in quarterly organic revenue, especially following earlier declines and improvement in sales in regions including China, has prompted renewed optimism about the outlook for European luxury goods. We'll explore how Dior's third-quarter return to growth shapes the...

Stock pickers are generally looking for stocks that will outperform the broader market. And while active stock picking...

Key Insights L.D.C's estimated fair value is €181 based on 2 Stage Free Cash Flow to Equity Current share price of...

Pernod Ricard SA ( EPA:RI ) will pay a dividend of €2.35 on the 26th of November. The dividend yield will be 5.3% based...

To the annoyance of some shareholders, The Blockchain Group ( EPA:ALCPB ) shares are down a considerable 41% in the...

Embention Sistemas Inteligentes, S.A.'s ( EPA:MLUAV ) price-to-sales (or "P/S") ratio of 11.7x may look like a poor...

Unfortunately for some shareholders, the EKINOPS S.A. ( EPA:EKI ) share price has dived 42% in the last thirty days...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...

Rexel reported third-quarter 2025 sales of €4.76 billion, representing 3% same-day growth, with strong contributions from high-growth sectors in North America, while reconfirming its full-year guidance for slightly positive sales growth, profitability, and cash flow. Additionally, the Board appointed Robert Schuchna, partner at Cevian Capital, as a non-independent member following a recommendation from Cevian, which owns about 23% of Rexel’s share capital. We'll assess how Rexel’s...

Alstom SA recently announced that Martin Sion will take over as Group Chief Executive Officer from April 2026, succeeding long-serving CEO Henri Poupart-Lafarge, with continuity ensured through a planned leadership transition period. Martin Sion brings decades of engineering and executive experience from the aerospace and defense sectors, which could introduce new perspectives to Alstom's leadership during a period of operational transformation. We will explore how the appointment of Martin...

Abivax recently announced new Phase 3 clinical data for obefazimod at the United European Gastroenterology Meeting, showing the therapy achieved clinically meaningful improvements in moderate-to-severely active ulcerative colitis and met its FDA primary endpoints for clinical remission at week 8 in both pivotal ABTECT trials. Additional safety findings highlighted a favorable profile with no new serious infection or malignancy signals across a large and diverse patient population, including...

Sartorius Stedim Biotech S.A. ( EPA:DIM ) led the ENXTPA gainers with a relatively large price hike in the past couple...

Despite an already strong run, Catering International & Services Société Anonyme ( EPA:ALCIS ) shares have been...

Gecina (ENXTPA:GFC) has seen its share price dip about 1% today, a move that stands out given the company's performance this month. Investors seem curious about recent market shifts and what they might signal for the stock's outlook. See our latest analysis for Gecina. After several months of choppy trading, Gecina’s recent 1% slip comes as momentum continues to cool. Its 30-day share price return sits at -4.5%, and the total shareholder return over the last year is down more than 18%. While...

Exail Technologies ( EPA:EXA ) shareholders won't be pleased to see that the share price has had a very rough month...

While EKINOPS S.A. ( EPA:EKI ) might not have the largest market cap around , it received a lot of attention from a...

Key Insights Given the large stake in the stock by institutions, Teleperformance's stock price might be vulnerable to...

Earlier this week, Nexans S.A. announced a sudden leadership transition, with Julien Hueber appointed as Chief Executive Officer effective immediately, succeeding Christopher Guérin, who will remain available for the transition until October 31, 2025. This rapid executive change signals a fresh direction for the company, as the Board seeks to generate new momentum while building on recent achievements in sustainable electrification. We'll explore how Julien Hueber's appointment as CEO could...

Key Insights Significant control over Interparfums by public companies implies that the general public has more power...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Carrefour fair value estimate is €21.05 Current share price of...

Mexedia Società Per Azioni S.B (ENXTPA:ALMEX) is trading at a Price-To-Sales Ratio of 1.2x, which is below its peer average of 2.1x and aligns with the broader European Telecom industry. Despite this apparent value, the company remains unprofitable, with losses widening at an average annual rate of 84.1% over the past five years. Margins have not improved, and ongoing instability in the share price means profitability remains elusive for investors looking for a sustained turnaround. See our...